Page last updated: 2024-08-23

pravastatin and Graft vs Host Disease

pravastatin has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, CS; Kim, TJ; Lim, JY; Min, CK; Yoon, HK1
Chiba, S; Goyama, S; Hamaki, T; Hirai, H; Hori, A; Imataki, O; Kami, M; Kanda, Y; Kishi, Y; Kojima, R; Komeno, Y; Makimoto, A; Mitani, K; Ogawa, S; Onishi, Y; Sakiyama, M; Takaue, Y; Tanosaki, R1

Trials

1 trial(s) available for pravastatin and Graft vs Host Disease

ArticleYear
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.
    Transplantation, 2005, Feb-15, Volume: 79, Issue:3

    Topics: Chronic Disease; Graft vs Host Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Th1 Cells; Th2 Cells

2005

Other Studies

1 other study(ies) available for pravastatin and Graft vs Host Disease

ArticleYear
Effects of pravastatin on murine chronic graft-versus-host disease.
    Transplantation, 2010, Oct-27, Volume: 90, Issue:8

    Topics: Animals; Chemokines; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Graft vs Host Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Minor Histocompatibility Antigens; Pravastatin; Skin Transplantation; Transplantation, Isogeneic

2010